Avicularin

CAS No. 572-30-5

Avicularin( —— )

Catalog No. M18833 CAS No. 572-30-5

Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 129 In Stock
10MG 192 In Stock
25MG 325 In Stock
50MG 486 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Avicularin
  • Note
    Research use only, not for human use.
  • Brief Description
    Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells.
  • Description
    Avicularin exhibits anti-inflammatory activity through the suppression of ERK signaling pathway in LPS-stimulated RAW 264.7 macrophage cells. Avicularin inhibits the accumulation of the intracellular lipids by decreasing C/EBPα-activated GLUT4-mediated glucose uptake in adipocytes and potently inhibiting fatty acid synthase.
  • In Vitro
    Cell Proliferation Assay Cell Line:Huh7 cells Concentration:25, 50, 100 μg/mL Incubation Time:12, 24, 36 and 48 h Result:Inhibited cell proliferation in a dose-dependent manner.Western Blot Analysis Cell Line:RAW 264.7 cells Concentration:10, 30, 100, 300 μM Incubation Time:1 h Result:Inhibited LPS-induced protein expression of iNOS and COX-2, release of pro-inflammatory cytokine IL-1β, degradation of cytosolic IκB, and phosphorylation of ERK.RT-PCR Cell Line:3T3-L1 cells Concentration:50 μM Incubation Time:6 days Result:Decreased PPARγ, C/EBPα, and aP2 mRNA levels approximately 28.7, 69.5, and 18.3%, respectively.
  • In Vivo
    Animal Model:ACLT (anterior cruciate ligament transection)-induced rats Dosage:0.5, 1, 2 mg/kg Administration:Injected into the articular cavity of the right knee, twice a week for 4 weeks.Result:Alleviated the tibial subchondral osteolysis, reduces bone loss, and increases the bone mass of tibial subchondral bone.Attenuated ECM degradation, the loss of Aggrecan and Collagen II in ACLT-induced rats. Decreased the MMP3 and MMP13 protein level. Animal Model:Rats with amyloid Beta-induced Alzheimer's disease Dosage:25, 50, and 100 mg/kg Administration:Oral administration, for 21 days Result:Enhanced cognition activity, and reversed the effects of amyloid beta-induced inflammatory response and excessive oxidative stress.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ERK
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    572-30-5
  • Formula Weight
    434.35
  • Molecular Formula
    C20H18O11
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (230.23 mM)
  • SMILES
    C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • PRX-08066 Maleic aci...

    PRX-08066 Maleic acid is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.

  • PXS-5153A

    PXS-5153A is an effective, selective, and fast-acting inhibitor of lysyl oxidase like 2/3 enzymes with enzymatic activity almost entirely blocked within 15 minutes. PXS-5153A could reduce crosslinks and ameliorates fibrosis.

  • Arazine

    Arazine can be a a substrate for isoprenylcysteine methyltransferase by competing with prenylated G protein or its receptors site. Arazine is a cell-permeable modulator of G protein and GPCR signaling.